Related Experiment Video
Updated: May 18, 2026
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Neurocognitive function after radiotherapy for paediatric brain tumours
Laetitia Padovani1, Nicolas André, Louis S Constine
1Department of Radiation Oncology and Paediatrics, CHU La Timone, Assistance Publique des Hôpitaux de Marseille, 264 Boulevard Jean Moulin, 13005 Marseille, France. laetitia.padovani@ap-hm.fr
Insights
Cranial radiation therapy (CRT) can cause long-term neurocognitive deficits in pediatric brain tumor survivors. Research reviews mechanisms, consequences, and potential interventions to mitigate this damage.
Area of Science:
- Neuroscience
- Pediatric Oncology
- Radiation Oncology
Background:
- The developing brain is vulnerable to neurotoxic agents.
- Cranial radiation therapy (CRT) for pediatric brain tumors can lead to significant neurocognitive deficits.
- These deficits impact academic achievement, memory, attention, and processing speed.
Purpose of the Study:
- To review the mechanisms and clinical consequences of CRT-induced neurocognitive damage in pediatric brain tumor survivors.
- To discuss the application of neuroimaging in identifying white matter injury post-CRT.
- To highlight potential interventions for minimizing neurocognitive impairment.
Main Methods:
- Review of existing literature on CRT effects on pediatric brain development.
- Analysis of neuroimaging studies identifying white matter injury.
- Discussion of current and emerging therapeutic strategies.
Main Results:
- CRT can cause axonal damage and disrupt white matter growth.
- Affected brain structures include the hippocampus, impacting memory and neurogenesis.
- Factors like radiation dose, volume, age, and individual susceptibility influence outcomes.
Conclusions:
- CRT-induced neurocognitive deficits are a significant concern for pediatric brain tumor survivors.
- Neuroimaging plays a crucial role in assessing treatment-related brain injury.
- Future research and interventions aim to protect cognitive function during cancer treatment.
Abstract:
The brain is highly vulnerable to neurotoxic agents during the prime learning period of a child's life. Paediatric patients with brain tumours who are treated with cranial radiation therapy (CRT) often go on to develop neurocognitive deficits, which are reflected in poor academic achievement and impaired memory, attention and processing speed. The extent of these delayed effects varies with radiation dose, brain volume irradiated, and age at treatment, and might also be influenced by genetic factors and individual susceptibility. CRT-induced impairment involves axonal damage and disruption of white matter growth, and can affect brain structures implicated in memory function and neurogenesis, such as the hippocampus. In this article, we review the underlying mechanisms and clinical consequences of CRT-induced neurocognitive damage in survivors of paediatric brain tumours. We discuss the recent application of neuroimaging technologies to identify white matter injury following CRT, and highlight new radiation techniques, pharmacological and neurological interventions, as well as rehabilitation programmes that have potential to minimize neurocognitive impairment following CRT.
